Aducanumab CAS 1384260-65-4

/in , /by

Identification

CAS Number

1384260-65-4

Name

Aducanumab

Properties

Safety Data

Symbol

WGK Germany

3

MSDS Download

Specifications and Other Information of Our

Known Application

Aducanumab CAS 1384260-65-4 is a human monoclonal antibody and is the first and only Alzheimer’s disease treatment to address the clear pathology of the disease by reducing amyloid plaques in the brain. ADUHELM™ is indicated for the treatment of Alzheimer’s disease. This indication was granted under accelerated approval for amyloid plaque reduction in patients treated with ADUHELM™.

General View of Documents

This product is sold exclusively through our sales company Watson International Limited, and please click the link below for details (https://www.watson-int.com/).